clinical trial · NCT07560618
Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
Integrative Skin Science and Research·phase4·recruiting·n = 40
ITCHAtopic DermatitisRoflumilast Cream 0.15%
brief summary
This study is being done to obtain descriptive classifications of pruritus using a patient directed survey system and assess change in pruritus over time in patients with Atopic Dermatitis over 4 weeks with use of topical Roflumilast cream 0.15% QD.
started
Jul 21, 2026
primary completion
Aug 1, 2027
completion
Aug 1, 2027
last updated
Aug 13, 2026
official title
A Phase 4, Open Label Study to Assess Descriptive Classification of Pruritus Over Time With Roflumilast 0.15% Cream in Patients With Atopic Dermatitis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol